Review



mouse anti drd1  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Santa Cruz Biotechnology mouse anti drd1
    Figure 3. GABABR deficiency in striatum neurons increases expression of cFos + <t>/drd1</t> + cells in CPu neurons. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant. #p < 0.05 versus 0 min in WT mice. †p < 0.05 versus 0 min in KO mice. *p < 0.05 versus WT mice. See also Supplemental Table 2 for details on statistics.
    Mouse Anti Drd1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 82 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti drd1/product/Santa Cruz Biotechnology
    Average 94 stars, based on 82 article reviews
    mouse anti drd1 - by Bioz Stars, 2026-03
    94/100 stars

    Images

    1) Product Images from "GABA B receptor signaling in the caudate putamen is involved in binge-like consumption during a high fat diet in mice."

    Article Title: GABA B receptor signaling in the caudate putamen is involved in binge-like consumption during a high fat diet in mice.

    Journal: Scientific reports

    doi: 10.1038/s41598-021-98590-9

    Figure 3. GABABR deficiency in striatum neurons increases expression of cFos + /drd1 + cells in CPu neurons. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant. #p < 0.05 versus 0 min in WT mice. †p < 0.05 versus 0 min in KO mice. *p < 0.05 versus WT mice. See also Supplemental Table 2 for details on statistics.
    Figure Legend Snippet: Figure 3. GABABR deficiency in striatum neurons increases expression of cFos + /drd1 + cells in CPu neurons. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant. #p < 0.05 versus 0 min in WT mice. †p < 0.05 versus 0 min in KO mice. *p < 0.05 versus WT mice. See also Supplemental Table 2 for details on statistics.

    Techniques Used: Expressing, Staining, Knock-Out

    Figure 6. Suppressive effects of baclofen on cFos + /drd1 + cell expression in the CPu were absent in KO mice. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice at 30 min on a high fat diet (HFD) in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice at 30 min on a HFD in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant, veh: vehicle, bac: baclofen. *p < 0.05 versus vehicle in WT mice. See also Supplemental Table 2 for details on statistics.
    Figure Legend Snippet: Figure 6. Suppressive effects of baclofen on cFos + /drd1 + cell expression in the CPu were absent in KO mice. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice at 30 min on a high fat diet (HFD) in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice at 30 min on a HFD in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant, veh: vehicle, bac: baclofen. *p < 0.05 versus vehicle in WT mice. See also Supplemental Table 2 for details on statistics.

    Techniques Used: Expressing, Staining, Knock-Out

    Figure 7. Schematic of role of GABABR signaling in striatum in suppression of binge-like consumption of a HFD. We suggest that gamma-aminobutyric acid type B receptor (GABABR) signaling in the caudate putamen (CPu) suppresses the binge-like consumption of a high fat diet (HFD) by inhibiting downstream of dopamine receptor d1 (drd1) signaling in the CPu. The figure image was drawn using PowerPoint 2017 (Microsoft, USA).
    Figure Legend Snippet: Figure 7. Schematic of role of GABABR signaling in striatum in suppression of binge-like consumption of a HFD. We suggest that gamma-aminobutyric acid type B receptor (GABABR) signaling in the caudate putamen (CPu) suppresses the binge-like consumption of a high fat diet (HFD) by inhibiting downstream of dopamine receptor d1 (drd1) signaling in the CPu. The figure image was drawn using PowerPoint 2017 (Microsoft, USA).

    Techniques Used:



    Similar Products

    94
    Bio-Techne corporation dopamine d1r/drd1 antibody (sg2-d1a)
    Dopamine D1r/Drd1 Antibody (Sg2 D1a), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dopamine d1r/drd1 antibody (sg2-d1a)/product/Bio-Techne corporation
    Average 94 stars, based on 1 article reviews
    dopamine d1r/drd1 antibody (sg2-d1a) - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Novus Biologicals mouse anti dopamine d1r drd1
    Mouse Anti Dopamine D1r Drd1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti dopamine d1r drd1/product/Novus Biologicals
    Average 94 stars, based on 1 article reviews
    mouse anti dopamine d1r drd1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    93
    Proteintech antibodies against mouse drd1
    Antibodies Against Mouse Drd1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against mouse drd1/product/Proteintech
    Average 93 stars, based on 1 article reviews
    antibodies against mouse drd1 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Novus Biologicals antibody mouse anti-dopamine d1r/drd1 clone sg2-d1a #nb110-60,017
    Antibody Mouse Anti Dopamine D1r/Drd1 Clone Sg2 D1a #Nb110 60,017, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody mouse anti-dopamine d1r/drd1 clone sg2-d1a #nb110-60,017/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    antibody mouse anti-dopamine d1r/drd1 clone sg2-d1a #nb110-60,017 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology mouse anti drd1
    Figure 3. GABABR deficiency in striatum neurons increases expression of cFos + <t>/drd1</t> + cells in CPu neurons. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant. #p < 0.05 versus 0 min in WT mice. †p < 0.05 versus 0 min in KO mice. *p < 0.05 versus WT mice. See also Supplemental Table 2 for details on statistics.
    Mouse Anti Drd1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti drd1/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    mouse anti drd1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology mouse anti-drd1 monoclonal antibody
    Figure 3. GABABR deficiency in striatum neurons increases expression of cFos + <t>/drd1</t> + cells in CPu neurons. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant. #p < 0.05 versus 0 min in WT mice. †p < 0.05 versus 0 min in KO mice. *p < 0.05 versus WT mice. See also Supplemental Table 2 for details on statistics.
    Mouse Anti Drd1 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-drd1 monoclonal antibody/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    mouse anti-drd1 monoclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Novus Biologicals mouse anti dopamine d1 receptor d1r
    Figure 3. GABABR deficiency in striatum neurons increases expression of cFos + <t>/drd1</t> + cells in CPu neurons. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant. #p < 0.05 versus 0 min in WT mice. †p < 0.05 versus 0 min in KO mice. *p < 0.05 versus WT mice. See also Supplemental Table 2 for details on statistics.
    Mouse Anti Dopamine D1 Receptor D1r, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti dopamine d1 receptor d1r/product/Novus Biologicals
    Average 94 stars, based on 1 article reviews
    mouse anti dopamine d1 receptor d1r - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Bio-Techne corporation dopamine d1r/drd1 antibody - bsa free
    Figure 3. GABABR deficiency in striatum neurons increases expression of cFos + <t>/drd1</t> + cells in CPu neurons. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant. #p < 0.05 versus 0 min in WT mice. †p < 0.05 versus 0 min in KO mice. *p < 0.05 versus WT mice. See also Supplemental Table 2 for details on statistics.
    Dopamine D1r/Drd1 Antibody Bsa Free, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dopamine d1r/drd1 antibody - bsa free/product/Bio-Techne corporation
    Average 90 stars, based on 1 article reviews
    dopamine d1r/drd1 antibody - bsa free - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 3. GABABR deficiency in striatum neurons increases expression of cFos + /drd1 + cells in CPu neurons. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant. #p < 0.05 versus 0 min in WT mice. †p < 0.05 versus 0 min in KO mice. *p < 0.05 versus WT mice. See also Supplemental Table 2 for details on statistics.

    Journal: Scientific reports

    Article Title: GABA B receptor signaling in the caudate putamen is involved in binge-like consumption during a high fat diet in mice.

    doi: 10.1038/s41598-021-98590-9

    Figure Lengend Snippet: Figure 3. GABABR deficiency in striatum neurons increases expression of cFos + /drd1 + cells in CPu neurons. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant. #p < 0.05 versus 0 min in WT mice. †p < 0.05 versus 0 min in KO mice. *p < 0.05 versus WT mice. See also Supplemental Table 2 for details on statistics.

    Article Snippet: They were then incubated in diluted blocking buffer (Blocking one, NACALAI TESQUE, Japan) and 0.2% sodium azide for 5 days at 4 °C with the following antibodies: rabbit anti-cFos (226 003, Synaptic Systems, Goettingen, Germany, RRID: AB_2231974), and mouse anti-drd1 (sc-33660, Santa Cruz Biotechnology, Dallas, TX, USA, RRID: AB_668813).

    Techniques: Expressing, Staining, Knock-Out

    Figure 6. Suppressive effects of baclofen on cFos + /drd1 + cell expression in the CPu were absent in KO mice. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice at 30 min on a high fat diet (HFD) in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice at 30 min on a HFD in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant, veh: vehicle, bac: baclofen. *p < 0.05 versus vehicle in WT mice. See also Supplemental Table 2 for details on statistics.

    Journal: Scientific reports

    Article Title: GABA B receptor signaling in the caudate putamen is involved in binge-like consumption during a high fat diet in mice.

    doi: 10.1038/s41598-021-98590-9

    Figure Lengend Snippet: Figure 6. Suppressive effects of baclofen on cFos + /drd1 + cell expression in the CPu were absent in KO mice. (A and C) Representative photographs showing the staining of cFos (green), dopamine receptor d1 (drd1) (red), and DAPI (blue) in the caudate putamen (CPu) (A) and nucleus accumbens (NAc) (C) of wild-type (WT) and knockout (KO) mice at 30 min on a high fat diet (HFD) in the binge group. White arrowheads show the colocalization of cFos and drd1. Scale bars: 50 μm. (B and D) cFos-positive cells in drd1-positive neurons (cFos + /drd1 +) in the CPu (B) and NAc (D) of WT and KO mice at 30 min on a HFD in the binge group. All values are mean ± SEM. Statistical analyses were performed using two-way factorial analysis of variance (ANOVA) followed by Sidak’s post-hoc test (B and D). ns: not significant, veh: vehicle, bac: baclofen. *p < 0.05 versus vehicle in WT mice. See also Supplemental Table 2 for details on statistics.

    Article Snippet: They were then incubated in diluted blocking buffer (Blocking one, NACALAI TESQUE, Japan) and 0.2% sodium azide for 5 days at 4 °C with the following antibodies: rabbit anti-cFos (226 003, Synaptic Systems, Goettingen, Germany, RRID: AB_2231974), and mouse anti-drd1 (sc-33660, Santa Cruz Biotechnology, Dallas, TX, USA, RRID: AB_668813).

    Techniques: Expressing, Staining, Knock-Out

    Figure 7. Schematic of role of GABABR signaling in striatum in suppression of binge-like consumption of a HFD. We suggest that gamma-aminobutyric acid type B receptor (GABABR) signaling in the caudate putamen (CPu) suppresses the binge-like consumption of a high fat diet (HFD) by inhibiting downstream of dopamine receptor d1 (drd1) signaling in the CPu. The figure image was drawn using PowerPoint 2017 (Microsoft, USA).

    Journal: Scientific reports

    Article Title: GABA B receptor signaling in the caudate putamen is involved in binge-like consumption during a high fat diet in mice.

    doi: 10.1038/s41598-021-98590-9

    Figure Lengend Snippet: Figure 7. Schematic of role of GABABR signaling in striatum in suppression of binge-like consumption of a HFD. We suggest that gamma-aminobutyric acid type B receptor (GABABR) signaling in the caudate putamen (CPu) suppresses the binge-like consumption of a high fat diet (HFD) by inhibiting downstream of dopamine receptor d1 (drd1) signaling in the CPu. The figure image was drawn using PowerPoint 2017 (Microsoft, USA).

    Article Snippet: They were then incubated in diluted blocking buffer (Blocking one, NACALAI TESQUE, Japan) and 0.2% sodium azide for 5 days at 4 °C with the following antibodies: rabbit anti-cFos (226 003, Synaptic Systems, Goettingen, Germany, RRID: AB_2231974), and mouse anti-drd1 (sc-33660, Santa Cruz Biotechnology, Dallas, TX, USA, RRID: AB_668813).

    Techniques: